Abstract
Multiple modalities of cognitive stimulation (CS) have been designed and tested in samples of patients with probable Alzheimer’s disease (AD). Despite the substantial inter-study variability, an overall positive impact of CS is reported. This impact has been especially observed in general measures of cognition. The mechanisms by which cognitive exercises would be beneficial for high-order cortical functions are still largely undetermined, however. When CS has been applied to patients with mild cognitive impairment (who are at the prodromal stage of AD) more stringent methodological criteria and designs were used and studies have been of greater clinical and research relevance. At this disease stage, a positive impact of CS has been reported in a range of different cognitive domains, and even at a neuro-computational level by the measurement of test-retest modifications of brain function. The effects of CS in healthy adults have also been studied. This population allows researchers to explore and test specific neural mechanisms possibly underlying the effect of pen-and-paper or computerised exercises. The evidence from these studies and those contributing to a better understanding of the pathophysiology of AD has led to devising forms of CS as preventive and therapeutical measures for neurodegenerative diseases based on novel frameworks of brain structure, function and connectivity. An extensive review of the literature was carried out to clarify whether CS is effective in AD and mild cognitive impairment and, together with the evidence from studies in healthy participants, to identify the relevant mechanisms that might sustain this effectiveness.
Keywords: Alzheimer’s disease, cognitive stimulation, cognitive training, mild cognitive impairment, neural changes, nonpharmacological treatment.
Current Alzheimer Research
Title:Cognitive Stimulation: The Evidence Base for its Application in Neurodegenerative Disease
Volume: 11 Issue: 5
Author(s): Matteo De Marco, Michael F. Shanks and Annalena Venneri
Affiliation:
Keywords: Alzheimer’s disease, cognitive stimulation, cognitive training, mild cognitive impairment, neural changes, nonpharmacological treatment.
Abstract: Multiple modalities of cognitive stimulation (CS) have been designed and tested in samples of patients with probable Alzheimer’s disease (AD). Despite the substantial inter-study variability, an overall positive impact of CS is reported. This impact has been especially observed in general measures of cognition. The mechanisms by which cognitive exercises would be beneficial for high-order cortical functions are still largely undetermined, however. When CS has been applied to patients with mild cognitive impairment (who are at the prodromal stage of AD) more stringent methodological criteria and designs were used and studies have been of greater clinical and research relevance. At this disease stage, a positive impact of CS has been reported in a range of different cognitive domains, and even at a neuro-computational level by the measurement of test-retest modifications of brain function. The effects of CS in healthy adults have also been studied. This population allows researchers to explore and test specific neural mechanisms possibly underlying the effect of pen-and-paper or computerised exercises. The evidence from these studies and those contributing to a better understanding of the pathophysiology of AD has led to devising forms of CS as preventive and therapeutical measures for neurodegenerative diseases based on novel frameworks of brain structure, function and connectivity. An extensive review of the literature was carried out to clarify whether CS is effective in AD and mild cognitive impairment and, together with the evidence from studies in healthy participants, to identify the relevant mechanisms that might sustain this effectiveness.
Export Options
About this article
Cite this article as:
Marco De Matteo, Shanks F. Michael and Venneri Annalena, Cognitive Stimulation: The Evidence Base for its Application in Neurodegenerative Disease, Current Alzheimer Research 2014; 11 (5) . https://dx.doi.org/10.2174/1567205011666140505120145
DOI https://dx.doi.org/10.2174/1567205011666140505120145 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
Call for Papers in Thematic Issues
New Advances in the Prevention, Diagnosis, Treatment, and Rehabilitation of Alzheimer's Disease
Aims and Scope: Introduction: Alzheimer's disease (AD) poses a significant global health challenge, with an increasing prevalence that demands concerted efforts to advance our understanding and strategies for prevention, diagnosis, treatment, and rehabilitation. This thematic issue aims to bring together cutting-edge research and innovative approaches from multidisciplinary perspectives to address ...read more
Current updates on the Role of Neuroinflammation in Neurodegenerative Disorders
Neuroinflammation is an invariable hallmark of chronic and acute neurodegenerative disorders and has long been considered a potential drug target for Alzheimer?s disease (AD) and dementia. Significant evidence of inflammatory processes as a feature of AD is provided by the presence of inflammatory markers in plasma, CSF and postmortem brain ...read more
Deep Learning for Advancing Alzheimer's Disease Research
Alzheimer's disease (AD) poses a significant global health challenge, with an increasing number of individuals affected yearly. Deep learning, a subfield of artificial intelligence, has shown immense potential in various domains, including healthcare. This thematic issue of Current Alzheimer Research explores the application of deep learning techniques in advancing our ...read more
Diagnostic and therapeutic biomarkers of dementia
Dementia affects 18 million people worldwide. Dementia is a syndrome of symptoms caused by brain disease, usually chronic or progressive, clinically characterized by multiple impairments of higher cortical functions such as memory, thinking, orientation, and learning. In addition, in the course of dementia, cognitive deficits are observed, which often hinder ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Baseline MRI Predictors of Conversion from MCI to Probable AD in the ADNI Cohort
Current Alzheimer Research The ATP-Binding Cassette Transporter-2 (ABCA2) Overexpression Modulates Sphingosine Levels and Transcription of the Amyloid Precursor Protein (APP) Gene
Current Alzheimer Research Natural Non-Trasgenic Animal Models for Research in Alzheimers Disease
Current Alzheimer Research Association of Neutrophil-Lymphocyte Ratio with Mild Cognitive Impairment in Elderly Chinese Adults: A Case-control Study
Current Alzheimer Research Gene-Gene and Gene-Environment Interaction on the Risk of Parkinson’s Disease
Current Aging Science Autoantibodies Profile in Matching CSF and Serum from AD and aMCI patients: Potential Pathogenic Role and Link to Oxidative Damage
Current Alzheimer Research Complement and Microglia in the Neuropathogenesis of HIV Infection: Pro- and Anti-Inflammatory Aspects
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Congenital Blood Coagulation Factor XIII Deficiency and Perinatal Management
Current Drug Targets 25OH-Vitamin D3 Levels in Obesity and Metabolic Syndrome—Unaltered in Young and not Correlated to Carotid IMT in All Ages
Current Pharmaceutical Design Protein Interaction Studies for Understanding the Tremor Pathway in Parkinson’s Disease
CNS & Neurological Disorders - Drug Targets High Throughput Screening Technology and the Small Molecules Modulating Aging Related Signals
Combinatorial Chemistry & High Throughput Screening Erythrocyte Cytoskeletal-plasma Membrane Protein Network in Rett Syndrome: Effects of ω-3 Polyunsaturated Fatty Acids
Current Proteomics The Roles of Phosphodiesterase 2 in the Central Nervous and Peripheral Systems
Current Pharmaceutical Design New Promises to Cure Cancer and Other Genetic Diseases/Disorders: Epi-drugs Through Epigenetics
Current Topics in Medicinal Chemistry Angiotensin II-Vasopressin Interactions in The Regulation of Cardiovascular Functions. Evidence for an Impaired Hormonal Sympathetic Reflex in Hypertension and Congestive Heart Failure
Endocrine, Metabolic & Immune Disorders - Drug Targets SIST-M-IR Activities of Daily Living Items that Best Discriminate Clinically Normal Elderly from those with Mild Cognitive Impairment
Current Alzheimer Research Apoptosis in Alzheimer Disease: A Mathematical Improbability
Current Alzheimer Research Editorial:Genomics and Epigenomics of Tumor and Aging Cells
Current Genomics The role of NADPH Oxidase in Vascular Disease – Hypertension, Atherosclerosis & Stroke
Current Pharmaceutical Design Thermal Taste and Anti-Aspiration Drugs: A Novel Drug Discovery Against Pneumonia
Current Pharmaceutical Design